These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 32416351

  • 21. Protective potential of non-dialyzable material fraction of cranberry juice on the virulence of P. gingivalis and F. nucleatum mixed infection.
    Polak D, Naddaf R, Shapira L, Weiss EI, Houri-Haddad Y.
    J Periodontol; 2013 Jul; 84(7):1019-25. PubMed ID: 23030239
    [Abstract] [Full Text] [Related]

  • 22. NOX1/2 activation in human gingival fibroblasts by Fusobacterium nucleatum facilitates attachment of Porphyromonas gingivalis.
    Ahn SH, Song JE, Kim S, Cho SH, Lim YK, Kook JK, Kook MS, Lee TH.
    Arch Microbiol; 2016 Aug; 198(6):573-83. PubMed ID: 27071620
    [Abstract] [Full Text] [Related]

  • 23. The Danger Signal Extracellular ATP Is an Inducer of Fusobacterium nucleatum Biofilm Dispersal.
    Ding Q, Tan KS.
    Front Cell Infect Microbiol; 2016 Aug; 6():155. PubMed ID: 27909688
    [Abstract] [Full Text] [Related]

  • 24. Quantitative real-time PCR combined with propidium monoazide for the selective quantification of viable periodontal pathogens in an in vitro subgingival biofilm model.
    Sánchez MC, Marín MJ, Figuero E, Llama-Palacios A, León R, Blanc V, Herrera D, Sanz M.
    J Periodontal Res; 2014 Feb; 49(1):20-8. PubMed ID: 23581569
    [Abstract] [Full Text] [Related]

  • 25. Antibacterial and antibiofilm activities of eugenol from essential oil of Syzygium aromaticum (L.) Merr. & L. M. Perry (clove) leaf against periodontal pathogen Porphyromonas gingivalis.
    Zhang Y, Wang Y, Zhu X, Cao P, Wei S, Lu Y.
    Microb Pathog; 2017 Dec; 113():396-402. PubMed ID: 29101062
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [A preliminary study on the effect of histatin 5 inhibiting Porphyromonas gingivalis and Fusobacterium nucleatum co-aggregation].
    Wang HY, Liu JW, Li Q, Tan LS, Lin L, Pan YP.
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2018 Mar 09; 53(3):150-156. PubMed ID: 29972970
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Characterization of extracellular polymeric matrix, and treatment of Fusobacterium nucleatum and Porphyromonas gingivalis biofilms with DNase I and proteinase K.
    Ali Mohammed MM, Nerland AH, Al-Haroni M, Bakken V.
    J Oral Microbiol; 2013 Mar 09; 5():. PubMed ID: 23372876
    [Abstract] [Full Text] [Related]

  • 33. Mixed infection with Porphyromonas gingivalis and Fusobacterium nucleatum in a murine lesion model: potential synergistic effects on virulence.
    Feuille F, Ebersole JL, Kesavalu L, Stepfen MJ, Holt SC.
    Infect Immun; 1996 Jun 09; 64(6):2094-100. PubMed ID: 8675312
    [Abstract] [Full Text] [Related]

  • 34. Antimicrobial photodynamic therapy alone or in combination with antibiotic local administration against biofilms of Fusobacterium nucleatum and Porphyromonas gingivalis.
    Tavares LJ, de Avila ED, Klein MI, Panariello BHD, Spolidório DMP, Pavarina AC.
    J Photochem Photobiol B; 2018 Nov 09; 188():135-145. PubMed ID: 30267963
    [Abstract] [Full Text] [Related]

  • 35. Strain-specific colonization patterns and serum modulation of multi-species oral biofilm development.
    Biyikoğlu B, Ricker A, Diaz PI.
    Anaerobe; 2012 Aug 09; 18(4):459-70. PubMed ID: 22771792
    [Abstract] [Full Text] [Related]

  • 36. Release and activation of human neutrophil matrix metallo- and serine proteinases during phagocytosis of Fusobacterium nucleatum, Porphyromonas gingivalis and Treponema denticola.
    Ding Y, Haapasalo M, Kerosuo E, Lounatmaa K, Kotiranta A, Sorsa T.
    J Clin Periodontol; 1997 Apr 09; 24(4):237-48. PubMed ID: 9144046
    [Abstract] [Full Text] [Related]

  • 37. Stimulation of Fusobacterium nucleatum biofilm formation by Porphyromonas gingivalis.
    Saito Y, Fujii R, Nakagawa KI, Kuramitsu HK, Okuda K, Ishihara K.
    Oral Microbiol Immunol; 2008 Feb 09; 23(1):1-6. PubMed ID: 18173791
    [Abstract] [Full Text] [Related]

  • 38. Selective inhibition of Porphyromonas gingivalis growth by a factor Xa inhibitor, DX-9065a.
    Matsushita K, Imamura T, Tancharoen S, Tatsuyama S, Tomikawa M, Travis J, Potempa J, Torii M, Maruyama I.
    J Periodontal Res; 2006 Jun 09; 41(3):171-6. PubMed ID: 16677284
    [Abstract] [Full Text] [Related]

  • 39. Immunological Pathways Triggered by Porphyromonas gingivalis and Fusobacterium nucleatum: Therapeutic Possibilities?
    de Andrade KQ, Almeida-da-Silva CLC, Coutinho-Silva R.
    Mediators Inflamm; 2019 Jun 09; 2019():7241312. PubMed ID: 31341421
    [Abstract] [Full Text] [Related]

  • 40. Effects of sub-minimal inhibitory concentrations of antibiotics on the morphology and surface hydrophobicity of periodontopathic anaerobes.
    Lee SY, Lee SY.
    Anaerobe; 2019 Feb 09; 55():107-111. PubMed ID: 30423437
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.